Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000078003-23-000050)

Filing Details

Accession Number:: 0000078003-23-000050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-21 18:07:27
Reporting Period:: 2023-03-17

Accepted Time:: 2023-03-21 18:07:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1782223	Pyxis Oncology Inc.	PYXS	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
78003	Pfizer Inc	66 Hudson Boulevard East New York NY 10001-2192		No	No	Yes	No
1776087	Pfizer Ventures (Us) Llc	66 Hudson Boulevard East New York NY 10001-2192		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2023-03-17	1,811,594	$2.76	5,952,263	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	1,080,507	Indirect	By Pfizer Ventures (US) LLC

Footnotes

The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.